The uncoupling of endothelial nitric oxide synthase (eNOS) due to reduced availability of its cofactor, tetrahydrobiopterin, may also contribute to the increased bioavailability of O2•− in pathological conditions associated with RAAS overactivity, such as hypertension and diabetes [64,65]. This evidence concerns the gene NOS3 and diabetes mellitus.